In the field of gene expression analysis, DNA microarray technology is having a major impact on many different areas including toxicology. For instance, a number of studies have shown that transcription profiling can generate the information needed to assign a compound to a mode-of-action class. In this study, we investigated whether compounds inducing similar toxicological endpoints produce similar changes in gene expression. In vitro primary rat hepatocytes were exposed to 11 different hepatotoxicants: acetaminophen, amiodarone, clofibrate, erythromycin estolate, isoniazid, α-naphtylylisothiocyanate, β-naphtoflavone, 4-pentenoic acid, phenobarbital, tetracycline and zileuton. These molecules were selected on the basis of their variety of hepatocellular effects observed such as necrosis, cholestasis, steatosis and induction of CYP P450 enzymes. We used a low-density DNA microarray containing 59 genes chosen as relevant toxic and metabolic markers. The in vitro gene expression data generated in this study were generally in good agreement with the literature which mainly concerns in vivo data. All the tested drugs generated a specific gene expression profile. Our results show that even with a relatively limited gene set, gene expression profiling allows a certain degree of classification of compounds with similar hepatocellular toxicities such as cholestasis, necrosis, ... The clustering analysis revealed that the compounds known to cause steatosis were linked, suggesting that they functionally regulate similar genes and possibly act through the same mechanisms of action. On the other hand, the drugs inducing necrosis and cholestasis were pooled in the same cluster. The drugs arbitrarily classified as the CYP450 inducers formed individual clusters. In conclusion, this study suggests that low-density microarrays could be useful in toxicological studies. 
Introduction
With increasing costs of new drug development, there is a crucial need to conduct toxicity evaluation as early as possible and on as many potential chemical leads as feasible. During the drug developmental process, undesired toxicity accounts for about one third of compound failures (Johnson and Wofgang, 2000) . Therefore, it is clear that new powerful technologies are needed as an alternative to classical toxicological tests for a rapid screening. Since some recent studies have shown the usefulness of DNA microarrays in toxicological studies, the scientific community is showing a growing interest for this kind of technology. The emerging field of "toxicogenomics" could be defined as the study of toxicological processes at the transcriptome level of a target organ or cell. It seems that DNA microarrays could be very helpful not only to predict drug induced toxicity but also to better understand mechanisms of actions of drugs (Fielden and Zacharewski, 2001; Storck et al., 2002) . In this context, gene expression microarrays could help to prioritize lead compounds.
DNA microarrays consist of DNA fragments corresponding to genes. The use of high density microarrays containing thousands of DNA fragments has the main advantage that the expression level of a large number of genes can be studied simultaneously. However, the major drawbacks are related to the high cost and the time taken for analysis and interpretation of the data. Low-density microarrays, even though they contain fewer genes, can still offer the ability to rapidly study gene expression changes following chemical exposure (de Longueville et al., 2002) .
However, it is clear that with low-density microarrays, the effects on genes not selected will obviously be missed.
While it may take weeks, months or even years before some traditional toxicological endpoints occur, specific changes in mRNA levels could occur within a few hours or days after exposure to chemical compounds. Toxicogenomics builds upon the fact that relevant toxicological outcomes are preceded by such changes in gene expression. A recent study revealed a strong correlation between the histopathology, clinical chemistry and gene expression profiles induced by 15 different known hepatotoxicants (Waring et al., 2001b) . In addition, comparison of gene expression profiles induced by new drugs with those induced by known toxicants obtained in a database could help identify and predict potential toxicities (Hamadeh et al., 2002a) . Recent studies have also shown that not only gene expression analysis reveals chemical specific profiles (Hamadeh et al., 2002b) but also that compounds belonging to a same class of toxicant yield to similar gene expression patterns that are distinct from other profiles generated by other class of chemicals (Bartosiewicz et al., 2001 ; Morgan et al., 2002) .
While the ultimate goal of toxicogenomics is to generate safe drugs for human, the majority of studies are performed on rodents despite the fact that the human predictability of standard rodent tests shows only 45% concordance (Johnson and Wolfgang, 2000) . However, primary hepatocytes are well suited for toxicogenomic studies because they display a certain level of metabolic activity and the liver is a major stage for toxic events (Waring et al., 2001a) .
Hepatotoxicity is a common reason for withdrawal of compounds from the market (Baker et al., 2003) . In addition, the use of cell culture models reduces the animal utilization and need for the synthesis of new compounds on a large scale (Baker et al., 2001) . However, it is also clear that there are a number of limitations in using in vitro approaches such as the functional differences observed in primary hepatocytes relative to the intact liver, the absence of interactions with biological entities (e.g. organs, blood) under in vitro conditions, the difficulty to select doses and time points which are representative of an in vivo situation.
Compared to the input of drug developers in toxicogenomics, the number of published studies on toxicogenomic involving the analysis of several compounds is still limited and mainly restricted to high-density microarrays (Burczynski et al., 2000; Bulera et al., 2001; Gerhold et al., 2001; Waring et al., 2001a; 2001b; Hamadeh et al., 2002a; 2002b; de Longueville et al., 2002) . In this study, we have used a low-density microarray containing 59 genes to analyze gene expression profiles generated in primary cultures of rat hepatocytes exposed to 11 different hepatotoxicants.
Materials and methods

Rat Hepatocyte Isolation
Wistar rats, 7-8 weeks old on the day of sacrifice, were obtained from Iffa Credo (L'Arbresles, France). Upon arrival and for the duration of the acclimatization period, animals had free access to UV-treated water and controlled rodent diet (Dietex, Witham, UK). The animal room temperature was maintained between 20 and 24°C with a relative humidity of 40 to 70%.
The light cycle was 12 h of light and 12 h of darkness.
Rats fasted for 24 h were anesthetized with an intraperitoneal injection of sodium pentobarbital (Pharmacie du Val d'Hony, Esneux, Belgium) as a saline solution (80 mg/kg) before liver perfusion and hepatocytes were isolated using a modification of Seglen's two step collagenase perfusion technique (Seglen, 1976) . A laparotomy was performed and a catheter was introduced into the portal vein, allowing the perfusion of the liver in situ at 37°C, with Baker, Deventer, Holland). The pH of this solution was kept at 7.4 with permanent bubbling of sterile carbogen (5% CO 2 , 95% O 2 ; Air Liquide Medical, Machelen, Belgium). A second catheter was introduced into the right atrium of the heart, permitting the recycling of the perfusion medium. After a few minutes perfusion, 90 U/ml collagenase "Hepatocytes qualified" (Invitrogen, Carlsbad, CA, USA) and 1.5 mmol/l CaCl 2 (Sigma, St-Louis, MO, USA) were added to the perfusion medium. After 10 min of perfusion, the liver was removed and the cells were dissociated, filtered and washed in WEC (William's E medium supplemented with 2 mmol/l L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10 % v/v foetal bovine serum (Invitrogen, Carlsbad, CA, USA). Hepatocytes number and viability were assessed by counting unstained and stained cells, after addition of trypan blue dye (Invitrogen, Carlsbad, CA, USA), using a Burker haemocytometer. The cell suspension was considered to be valid and used when the cell viability was greater than 80 %.
Cytotoxicity assessment
To ensure that sublethal concentrations of test compounds were used in the experiment to establish the gene expression profile, the cytotoxicity was assessed in vitro, on freshly isolated male adult rat hepatocytes using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] reduction method (Otoguro et al., 1991) .
Compound solutions
The different compounds were freshly dissolved at 100-fold the final concentrations 
Hepatocyte incubations and MTT reduction assay
Freshly isolated hepatocytes were seeded in collagen S-precoated 24-well plates (Becton Dickinson, Franklin Lakes, NJ, USA) at a density of 10 5 viable cells/cm 2 for 3 h at 37°C under a 5% CO 2 /95% humidified atmosphere in WEC (William's E medium supplemented with 2 mmol/l L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 10% v/v foetal bovine serum (Invitrogen, Carlsbad, CA, USA)). After cell attachment, the medium was replaced with 1 ml of compound or vehicle solution, and the cells were incubated for a further 24 h before endpoint measurement. Compounds at the different concentrations and vehicles were tested in triplicates. Male rat hepatocytes were incubated with all the compounds while female rat hepatocytes were only incubated with acetaminophen.
The cytotoxicity was then assessed using the MTT reduction method. The test medium was discarded and fresh medium containing 1 mg/ml MTT (Sigma, St-Louis, MO, USA) was added to the monolayers. After a 3 h incubation at 37°C in a humid atmosphere (5% C0 2 : 95% air), the medium was removed and the formazan dye formed by succinyl dehydrogenase-catalysed reaction solubilized with isopropranol. The absorbance was then measured at 550 nm using a microtiter plate reader SpectramaxPlus (Molecular Devices Corporation, Sunnyvale, CA, USA).
The toxic effect of each compound at the different concentrations was expressed as the percentage of the absorbance determined for control cells incubated with the corresponding vehicle. The concentration that produces a change of 50% (EC 50 ) in this endpoint assay was calculated by non-linear iterative adjustment using the Levenburg Marquardt algorithm (XL fit
Windows from Molecular Devices, Sunnyvale, CA, USA).
Gene expression analysis
In order to evaluate the reliability of microarray experiments and to obtain an accurate gene expression profile for each compound, three independent hepatocyte preparations were carried out for each compound. A microarray experiment was performed on each hepatocyte preparation. The microarray experiment included the following steps; mRNA extraction, labeled cDNA synthesis and microarray hybridization. In summary, three hybridization on microarray were performed for each compound (n=3).
Cell treatments
It has to be noted that for each drug and its control, the same hepatocyte preparation was used. In addition, the effect of each hepatotoxicant was tested on three independent hepatocyte preparations originating from three different rats.
Cells were seeded at 10 5 cells/cm 2 in collagen S-precoated 75 cm 2 flasks using WEC medium (15 ml/flask) (Invitrogen, Carlsbad, USA). Hepatocytes were then incubated at 37°C under a 5% CO 2 /95% humidified atmosphere and allowed to attach for 3 h prior to the incubation with the reference compounds. 
Synthesis of labeled cDNA
Labeled cDNA were prepared using 2 µg of mRNA. Three synthetic poly(A)+tailed RNA standards were spiked at three different amounts (10 ng, 1 ng and 0.1 ng per reaction)
into the purified mRNA as required by the microarray kit (EAT, Namur, Belgium). The RNA standards are used for quantification and estimation of experimental variation introduced during labeling and analysis. For more details concerning the cDNA preparation, please refer to de Longueville et al. (2002) .
Microarray design and hybridization
The DualChip rat hepato (EAT, Namur, Belgium) contains two arrays per slide with a range of genes involved in basic cellular processes such as drug metabolism, stress responses, cell proliferation, cell cycle activation, transcription, inflammation, apoptosis (de Longueville et al., 2002) . To evaluate the reliability of the experimental data, several positive and negative hybridization and detection controls are included on the microarray. For normalization, three internal standard controls and 8 housekeeping genes were arrayed on the slides.
The DualChip rat hepato hybridization was carried out according to the manufacturer's instructions as reported in de Longueville et al. (2002) . The detection was performed by using a cyanin-3 streptavidin conjugate (Amersham Pharmacia Biotech, Buckinghamshire, England).
Imaging, statistical analysis and clustering
After Hybridization, arrays were scanned using the GMS 418 laser confocal scanner (Genetic Microsystem, Woburn, MA, USA) at a resolution of 10 µm. To maximize the dynamic range of microarrays, the same arrays were scanned using different photomultiplier settings (PMT). The use of different intensities allows the quantification of both the high and low copy expressed genes. After image acquisition, the scanned 16-bit image was used to quantify the signal intensities with the ImaGene 4.1 software (BioDiscovery, Los Angeles, CA, USA). The fluorescent intensity of each DNA spot (average of intensity of each pixel present within the spot) was calculated using local mean background subtraction. A signal was accepted if the average intensity after background subtraction was at least 2.5 fold higher than its local background. The two intensity values of the duplicate DNA spots were averaged and used to determine the intensity ratio between the reference and the test samples. Very bright element intensities (saturated signals, highly expressed genes) were deemed unsuitable for accurate quantification because they underestimated the intensity ratios and were excluded from further analysis.
Several potential sources of experimental variation could occur during cDNA synthesis, labeling, hybridization and indirect detection steps. To take into account these possible variations, the data were normalized in a two step procedure. The values were first corrected using a factor calculated from the intensity ratios of the internal standards in the references and test samples. The presence of the three internal standard probes at two different locations of the microarray allowed to measure a local background and to evaluate the microarray homogeneity, which is taken into account in the normalization (Schuchhardt et al., 2001) .
However, as the internal standard control does not take into account the purity and quality of the mRNA, a second step of normalization was performed based on the expression levels of the housekeeping genes. This process involved calculating the average intensity from a set of housekeeping genes. Among these housekeeping genes, only genes for which the expression was not changed after a particular treatment were taken into account for the normalization.
Indeed, any drug may affect the expression of some of the housekeeping genes.
The variance of the normalized set of housekeeping genes (except those affected by the treatment) was used to generate an estimate of expected variance, leading to a predicted confidence interval (CI) to test the significance of the ratios obtained (Chen et al., 1997; de Longueville et al., 2002) . Ratios outside the 99% confidence interval were determined to be significantly different. The analysis of variance (ANOVA) was used to examine the data.
Before performing the cluster analysis, ratios falling inside the 99 % confidence interval were replaced by the value 1. Clusters of hybridization profiles were created with the s-plus 2000 software (Insightful, Seattle, WA, USA) using the classical agglomerative hierarchical with the single link. The distance computed between two hybridization profiles corresponds to the Manhattan distance (Van Custem et al., 1994) .
Validation of relative gene expression by real-time PCR
The single strand-cDNA (ss-cDNA) was synthesized from 0.5µg mRNA according to the RNA labeling protocol described in de Longueville et al. (2002) with the following minor modifications: (1) a DNAse treatment of mRNA was performed prior to cDNA synthesis; (2) the dNTP mixture contained dGTP, dATP, dTTP and dCTP each at 500µM but no biotinylated dCTP; (3) the second addition of reverse transcriptase was omitted.
Gene specific primers correspond to the gene sequence present on the DualChip rat hepato (EAT, Namur, Belgium). Forward and reverse primers for real-time PCR amplification were designed with the Primer Express Software (PE Applied Biosystem, Foster City, CA, USA).
Real time PCR was performed on 6 genes, namely, CYP 2B1/2, CYP 3A, GST Ya, Smp30, GAPDH (house keeping gene) and ribosomal protein S9 (house keeping gene).
mRNA extracted from hepatocytes exposed to PB and CLO was used in the real time PCR (n=2) and each reaction was performed in triplicate.
PCR reaction mixtures contained of 12. concentrations. For these three compounds, the maximal reduction of the MTT end-point was 35, 12, and 18% respectively for 300 µM zileuton, 10 mM ISN and APAP (male).
Consequently, EC 50 values for zileuton, ISN and APAP (male) are higher than the highest concentrations tested. Finally, the female rat hepatocytes were more susceptible to APAP toxicity, with a decrease in the MTT metabolism of 67% compared to only 18% in male rat hepatocytes at a concentration of 10 mM.
Analysis of gene expression modifications induced by the hepatotoxicants
Vehicle treated samples
Hepatocellular gene expression changes induced by DMSO and DMF (the solvents used to dissolve the test compounds) are shown in Fig. 2 . Acyl-Co-oxidase, involved in peroxisome proliferation and HGPT (hypoxanthine guanine phosphoribosyl transferase), a housekeeping gene, were respectively up-and down-regulated, by DMSO (p<0.01). On the other hand, two genes implicated in stress responses, namely GSH reductase and MDR-1b (multi-drug resistance) were down-regulated by DMF (p<0.01).
Hepatotoxicant treated samples
A global view of the different gene expression profiles induced by the various treatments is presented in Fig. 3 as well as an example of the microarray pictures obtained after hybridization.
Cytochrome P450s inducers
Different subfamilies of CYP P450 1A, 2B, 3A and 4A were significantly induced by BNF, PB, zileuton and CLO (p<0.01, Fig. 3 and Fig 4A) . Expression of the major CYP P450
genes was increased by a factor of at least 25. For example BNF, PB and CLO induced CYP1A1, 2B, and 4A1 by a factor 25.41, 45.01 and 33.03 respectively. In addition, PB decreased the expression of CYP4A1 ( Fig. 3 and 4A ). An overall view of the data is presented in Fig. 4B . CLO treatment significantly changed the expression of 12 genes included on the microarray versus 7 genes for zileuton and 6 genes for PB and BNF.
Drugs inducing hepatocellular necrosis
The data revealed significant gene expression changes for 10 and 11 genes after a treatment with ISN and APAP, respectively ( Fig. 3 and 4B) . A comparison among the drugs inducing necrosis shows that 4 genes implicated in phase I metabolism (CYP3A1 and AcylcoA-oxidase), phase II metabolism (Glutathione S-transferase Ya) (GST Ya) and growth arrest and DNA damage response (GADD153) followed the same tendency (Fig. 4) . In addition, the gene expression profiles were not identical between female and male hepatocytes exposed to APAP. Seven genes were differentially expressed in response to APAP. APOJ, albumin, fibronectin were induced to a greater extent in female hepatocytes whereas MDR-1b and
Ornithine decarboxylase (ODC) were only repressed in male hepatocytes treated with APAP,
respectively. In addition, the UDP-glucuronosyltransferase gene (UDPGT 1A6) implicated in phase II metabolism was differentially regulated in male and female hepatocytes exposed to APAP. Finally, 7 genes followed the same tendency after treatment to APAP in male and female hepatocytes (Fig. 4B ).
Drugs inducing hepatocellular cholestasis
The expression of 3 genes involved in apoptosis (Bcl-2), phases I (CYP 3A1) and II (UDPGT 1A) metabolism were significantly up-regulated in rat hepatocytes after a treatment with ERY whereas Bax was down-regulated ( Fig. 3 and 4C 
Tetracycline, pentenoic acid and amiodarone
After tetracycline treatment, the expression of only 3 genes was changed; CYP4A1 and GADD153 were up-regulated while senescence marker protein-30 (Smp30) was downregulated ( Fig. 3 and 4D ). Three genes were also found to be differentially expressed after pentenoic acid and AM treatments. CYP4A1 and C-Jun were up-regulated and Smp30 was down-regulated by pentenoic acid. On the other hand, AM significantly induced the expression of cytochrome-c-oxidase and CYP4A1 and repressed the expression of Smp30.
Both CYP 4A1 and Smp30 transcript levels were significantly up-and down-regulated by tetracycline, pentenoic acid and AM ( Fig. 3 and 4D ).
Gene expression validation
Based on data collected from the microarray technique and presented in Fig 4A , the expression profile was validated for 6 genes responsive to CLO and PB treatment (CYP 2B1/2, CYP 3A, GST Ya, Smp-30, GAPDH and ribosomal protein S29) (Fig. 5) .
Real time PCR data revealed that CYP 2B1/2, CYP 3A1, and GST-Ya were induced 189.2, 14.66 and 3.95 times in PB treated hepatocytes (Fig. 5B) . On the other hand, the expression of smp30 was repressed by a factor 0.56 in the cells exposed to PB. The expression of GADPH and ribosomal S29 was not affected by PB as the ratios were quite close to 1. Fig. 5B shows as well that CLO changed the expression of CYP 2B1/2, CYP 3A1
and GST-Ya by a factor 100.33, 1.97, and 2.07. The expression of smp30 is not affected by CLO as the ratios were quite close to 1.
The gene expression measured by the means of DNA microarrays followed the same tendency for the 6 genes measured
Clustering analysis
The comparison of all gene expression profiles generated by the 11 reference compounds revealed that six different clusters were observed (Fig. 6 ). The first cluster contains tetracycline, pentanoic acid and AM. The second one includes APAP, ANIT, ERY, and ISN. Four other clusters were formed by individual drugs that are BNF, PB, zileuton and CLO.
Discussion
In the present study, we used a low-density microarray containing 59 genes to analyze the gene expression profiles generated in primary cultures of rat hepatocytes exposed to 11 different known hepatotoxicants. The drugs were pooled into 4 groups labeled necrosis (ISN and APAP), cholestasis (ERY and ANIT), steatosis (tetracycline, 4-pentenoic acid and AM), and induction of CYP P450 subfamilies (CLO, BNF, PB and zileuton).
Our main goal was to analyze changes in gene expression levels induced by these drugs and to determine if the transcription profiles would permit a classification of compounds associated signatures.
Male hepatocytes were used for all drugs except for APAP for which female hepatocytes were also used. Indeed, APAP is known to produce sex-dependent hepatotoxicity in young adult rats (Tarloff et al., 1996) and consequently we expected to see some modifications in gene expression between male and female hepatocytes after a treatment with APAP. Incubation conditions with compounds can vary considerably between toxicological studies leading to various results.
Based on a previous study dealing with the kinetic of gene expression (hepatocytes exposed to PB for 24, 48 or 72 h), 24h was selected because this time point could provided for PB a good gene expression response. 24 h was also selected for the other drugs used in this study because it would most likely provide a complete gene response in hepatocytes without the interference of significant secondary responses that could be encountered at later. In addition, in vitro, a time of 24 h after treatment has been frequently selected to analyze gene expression modifications (Baker T.K et al.; , Waring et al., 2001a . The range of concentration tested in the cytotoxicity assay was based on preliminary assays using a wide range of concentrations and concentrations of the different compounds selected for the gene expression experiment were chosen based on cell viability assays (MTT curve). For all compounds, the selected concentrations did not induce any cell death (even for female hepatocytes exposed to APAP after curve correction see Fig. 1 ) but were generally close to the lowest concentrations inducing cell mortality. This approach was used since literature data were not available for many compounds regarding to the concentrations required to elicit toxic effects on hepatocytes either under in vitro nor in vivo conditions. Based on mechanisms of action and differential induced-toxicity, it is almost impossible to test the different classes of molecules in the same range of concentrations. For example, toxicity is observed at different doses for the different molecules.
Although the mode of action of BNF, CLO, PB, and zileuton are differents, we arbitrarily pooled these drugs because they are inducers of cytochrome P450 isoforms (Sundseth and Waxman, 1992; Gerhold et al., 2001) . BNF is an aromatic hydrocarbon that induces the expression of CYP1A family by activating the Aryl hydrocarbon (Ah) receptor (Denison and Heath-Pagliuso, 1998) . In the present study, induction of gene encoding CYP1A and several phase II enzymes namely UDPGT1A6 and GST Ya was also observed in rat hepatocytes after a BNF treatment as reported elsewhere (Maheo et al., 1997; Saarikoski et al., 1998) .
The barbiturate PB induces the transcription of the rat gene CYP2B and CYP3A (Frueh et al., 1997; Meyer and Hoffmann, 1999) through the constitutive androstane receptor (CAR) (Honkakoski et al., 1998; Masahiko and Honkakoski, 2000) . In our study, PB induced CYP2B, CYP3A and repressed CYP4A1. CYP4A1 is involved in the ω-hydroxylation of fatty acids (Gibson et al., 1982) and therefore a down regulation could lead to cellular dysfunction. Induction of genes encoding phase II metabolism enzymes (GST Ya and UDGT1A) was also observed in our study. In addition, the mRNA level of the senescence marker protein-30 (Smp30) was significantly reduced following PB treatment as reported in other studies (Fujita et al., 1999) .
CLO, a lipid lowering agent, triggers peroxisome proliferation in rodents and induces genes involved in the β-oxidation of fatty acids by the activation of the peroxisome proliferator-activated receptor alpha (PPARα) (Simpson, 1997; Lindquist et al., 1998; Corton et al., 2000) . CLO is known to induce members of the CYP4A subfamily genes (Surry et al., 2000 and present study). CLO significantly induced the expression of CYP 2B, CYP 3A, GST ya, theta5 and UDPGT1A as reported elsewhere (Ritter and Franklin, 1987; Ronis et al., 1994; Jemnitz et al., 2000) . In our study, increased lipid β-oxidation in response to CLO is supported by the induction of genes encoding peroxisomal enzymes such as acyl-CoA oxidase and peroxisomal enoyl-CoA-hydratase.
Zileuton, a 5-lipoxygenase inhibitor, is considered as a moderate inducer of CYP 450 (Rodrigues and Machinist, 1996) and it induced CYP2B in our study. However, zileuton also significantly modified the expression of GADD153, Erk1, Histone deacetylase (Hdac),
Ferritin subunit H, fibronectin and HMG-CoA-synthetase (3-hydroxy-3methylglutaryl-CoAsynthetase). A comparison of our data with other studies is difficult since, to our knowledge, the effect of zileuton on gene expression has not been published yet.
The next compounds studied were ISN and APAP which are known to induce necrosis. ISN is a first-line drug in the prophylaxis and treatment of tuberculosis (Sadaphal et al., 2001) . Little is known about the effect of ISN on gene expression. In our study, ISN induced CYP3A, GST Ya, GADD153, Hsp70, HO-2 (heme oxygenase 2), transferin and cytochrome c-oxidase.
APAP is known to induce the depletion of glutathione and cell death (Ray and Jena, 2000) , impair the mitochondrial respiration (Burcham and Harman, 1991) and interfere with Ca ++ homeostasis (Salas and Corcoran, 1997) . However so far, the exact mechanism of action of acetominophen has not been completely elucidated although recent reports have identified the constitutive androstane receptor as a regulator of APAP hepatotoxicity (Zhang and Huang, 2002) . APAP is mainly metabolized by cytochromes P450 (CYP 3A), by glucuronidation and sulforination pathways (Tygstrup et al., 2002) . Our data show that, APAP changed the expression of genes implicated in drug metabolism (induction of CYP 3A1, GST Ya, UDGT1a, UDGT1a6), stress response (repression of MDR-1b, induction of Hsp70), DNA repair (induction of GADD153 and repression of MGMT) and oncogenesis (induction of cmyc). It is noteworthy that GADD 153 and Hsp70 have been associated with the induction of apoptosis (Fontanier-Razzaq et al., 1999; Reilly et al., 2001) . APAP is also known to produce sex-dependent hepatotoxicity in young adult rats (Tarloff et al., 1996) . Our data reveal some important gene expression differences between male and female rat hepatocytes. For instance, APOJ, albumin and fibronectin were only induced in female hepatocytes, whereas repression of MDR-1b and induction of ODC only occurred in male hepatocytes.
Intra-hepatic cholestasis has been reported to occur during ERY and ANIT therapy (Orsler et al., 1999) . In our study, CYP3A and Bcl-2 were induced by both drugs as reported elsewhere (Que et al., 1997; Celli et al., 1998) and Bax was repressed and induced by ERY and ANIT, respectively. Aoshiba and co-workers (1995) also reported the effects of ERY on apoptotic genes. The increased of Bcl-2 expression is protective against apoptosis due to its intracellular antioxidant action (Gottlieb et al., 2000) . In addition to these apoptotic genes,
ANIT up-regulated GST-Ya and theta 5 as already reported by other studies (Lesage et al., 2001; Ohta et al., 2001) , PCNA (Ranganna et al., 2000) , c-myc, Hsp70, fibronectin, alpha-2-macroglobulin and ODC. However, the correlation between ANIT toxicity and these genes is not yet established.
Tetracycline, pentenoic acid and AM are known to induce hepatocellular steatosis (Loscher et al., 1993; Fromenty and Pessayre, 1995) . In the present study, these three compounds up-and down-regulated CYP4A1 and Smp30, respectively. Smp30 seems to play a critical role in the highly differentiated functions of the liver and its down-regulation may contribute to hepatic deterioration of cellular functions induced by steatosis (Fujita and Shirasawa, 1999; Ishigami et al., 2002) . CYP4A induction always accompanies any substantial drug-dependent increases in beta-oxidation (Tang et al., 1995; Amacher and Martin, 1997) . Robertson and co workers (2001) suggested that the induction of CYP4A
could be used as a good marker to assess steatosis injury. Other genes were differently expressed after tetracycline, pentenoic acid and AM treatments. For instance, tetracycline induced the expression of GADD153, a growth arrest and DNA damage gene. On the other hand, pentenoic acid induced C-Jun, a nuclear transcription factor and such events may lead to toxic events (Kovary and Bravo, 1991; Chung et al., 2001) .
Microarray measurements are usually semi-quantitative, with compression of values occurring at high-fold changed (Gerhold et al., 2001; Rajeevan et al., 2001; Yuen et al., 2002) but generally the data generated by microarray are in agreement with real time PCR results. In the present study, it was shown that the 6 genes measured with both technologies followed the same tendency for PB and CLO treated hepatocytes. Indeed, a compression of the values occurs at high-fold changes in expression but as observed, the quantifications made by the 2 methods are well correlated.
Even with a relatively limited gene set, all the 11 compounds gave rise to discernable gene expression profiles as already obtained with high-density microarrays (Hamadeh et al., 2002b; Morgan et al., 2002) . When clustering analysis is performed, it has to be noted that drugs inducing similar endpoints (e.g. cholestasis) may trigger different mechanism of actions. Thus, such drugs will not necessarily change the expression of the same set of genes.
BNF, PB, CLO and zileuton arbitrarily pooled in the CYP450 inducers formed four individual clusters, which confirmed that they act through different mechanisms of action. The present study also shows that some compounds belonging to the same class of toxicant were linked, suggesting that they target similar genes and possibly through the same mechanism of action.
For instance, a cluster was formed for tetracycline, pentenoic acid and amiodarone, drugs that are known to induce steatosis. On the other hand, the drugs inducing necrosis (APAP and ISN) and cholestasis (ANIT and ERY) were pooled in the same cluster which can be divided in two sub-clusters (firstly: ANIT and APAP and secondly: ISN and ERY). Interestingly, APAP and ANIT which belong to the cholestasis and necrosis groups, respectively, are also known to be inducers of apoptosis. Thus, this may explain why both drugs were clustered together. However, it has to be said that the low number of genes studied may also diminish the power of the clustering analysis.
The use of cultured hepatocytes to model hepatotoxicity has proven to be a valuable tool despite some limitations (see introduction for more details). Some reports have shown that gene expression data showed a good correlation between in vitro and in vivo models. For instance, hepatocytes treated with PPARα agonist fenofibrate produced gene expression changes characteristic of the in vivo response in rat liver (Baker et al., 2003) . The data revealed remarkable similarities in both the affected biological pathways and the rank-order magnitude of the response. The present study shows also a good correlation with regard to induction and repression of gene expression obtained in primary rat hepatocytes when compared to in vivo data.
Low-density microarrays seem to represent a useful tool to select drug candidates early in the development in conjunction with other data (e.g. toxicokinetic and pharmacological studies). For instance, drugs that do not change the expression of genes implicated in phase-1 and -2 metabolisms could be of particular interest. In addition, another attractive application could be to compare gene expression patterns generated by a key compound and its analogs. This would allow the selection of the best analogs based on gene expression comparison.
In conclusion, the in vitro gene expression data generated in this study were in good agreement with the literature which mainly concerns in vivo data. Hamadeh, H. K., Bushel, P. R., Jayadev, S., DiSorbo, O., Bennett, L., Li, L., Tennant, R., Stoll, R., Barrett, J. C., Paules, R. S., Blanchard, K., and Afshari, C. A. (2002a) . Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67,232-240.
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MTT reduction assay
